UK-based OrganOx has received $142m in primary and secondary equity financing to propel the growth of its metra platform ...

A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and secondary equity financing.

OrganOx, with its system for actively preserving viable donor tissue ahead of a transplant procedure, has raised $142 million ...

OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.

OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, successfully completed a $142 million primary and secondary ...

Organox Ltd. raised $142 million in financing to accelerate the growth of its Metra platform that preserves and transport livers for transplantation. The funds will allow the company to strengthen its ...

Stuge, MD, MBA, and Executive Chairman at OrganOx. “We’re thrilled to back OrganOx as they advance a technology platform that successfully addresses the quadruple aim of healthcare, benefitting ...

Financing strengthens OrganOx to expand its leadership position in organ technologyOXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025., a leading organ medical technology company, successfully co ...

OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, successfully completed a $142 million primary and secondary equity ...